Case number 2017-2376
Forest Laboratories, LLC v. Breckenridge Pharmaceutical > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 22, 2019 | 10 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [608923] [17-2369, 17-2370, 17-2372, 17-2373, 17-2374, 17-2375, 17-2376, 17-2389, 17-2412, 17-2436, 17-2438, 17-2440, 17-2441] [JAB] [Entered: 05/22/2019 10:07 AM] (2) |
| Mar 14, 2019 | 8 | OPINION filed for the court by Prost, Chief Judge; Dyk, Circuit Judge and Moore, Circuit Judge. Precedential Opinion. [592742] [17-2369, 17-2370, 17-2372, 17-2373, 17-2374, 17-2375, 17-2376, 17-2389, 17-2412, 17-2436, 17-2438, 17-2440, 17-2441] [PBC] [Entered: 03/14/2019 09:26 AM] (16) |
| Mar 14, 2019 | 9 | JUDGMENT filed. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [592746] [17-2369, 17-2370, 17-2372, 17-2373, 17-2374, 17-2375, 17-2376, 17-2389, 17-2412, 17-2436, 17-2438, 17-2440, 17-2441] [PBC] [Entered: 03/14/2019 09:31 AM] (2) |
| Aug 11, 2017 | 3 | Entry of appearance for Beth D. Jacob as principal counsel for Appellant Breckenridge Pharmaceutical Inc.. Service: 08/11/2017 by email. [453273] [Beth Jacob] [Entered: 08/11/2017 10:55 AM] (0) |
| Aug 11, 2017 | 4 | Entry of appearance for Cliff Katz as of counsel for Appellant Breckenridge Pharmaceutical Inc.. Service: 08/11/2017 by email. [453274] [Beth Jacob] [Entered: 08/11/2017 10:56 AM] (0) |
| Aug 11, 2017 | 5 | Certificate of Interest for the Appellant Breckenridge Pharmaceutical Inc.. Service: 08/11/2017 by email. [453276] [Beth Jacob] [Entered: 08/11/2017 10:57 AM] (0) |
| Aug 11, 2017 | 6 | Docketing Statement for the Appellant Breckenridge Pharmaceutical Inc.. Service: 08/11/2017 by email. [453277] [Beth Jacob] [Entered: 08/11/2017 10:58 AM] (0) |
| Aug 11, 2017 | 7 | NOTICE OF DEFICIENCY: Entries of appearance [3] and [4], the certificate of interest [5], and the docketing statement [6] filed by Appellant Breckenridge Pharmaceutical Inc. in 17-2376 are submitted in a trailer case and therefore cannot be accepted for filing at this time. All filings must be made in lead appeal 17-2369 only. As these documents have already been filed in lead appeal, no further action is required at this time. [453293] [MJL] [Entered: 08/11/2017 11:19 AM] (0) |
| Aug 2, 2017 | 1 | Appeal docketed. Received: 08/01/2017. [450875] [MJL] [Entered: 08/02/2017 10:55 AM] (17) |
| Aug 2, 2017 | 2 | Note to file: The following cases are consolidated: 17-2369 (Lead) with 17-2370, -2372, -2373, -2374, -2375, -2376 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [450877] [17-2369, 17-2370, 17-2372, 17-2373, 17-2374, 17-2375, 17-2376] [MJL] [Entered: 08/02/2017 11:00 AM] (0) |
